Stoke Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell STOK and other ETFs, options, and stocks.

About STOK

Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. 

CEO
Ian Frederick Smith
CEOIan Frederick Smith
Employees
170
Employees170
Headquarters
Bedford, Massachusetts
HeadquartersBedford, Massachusetts
Founded
2014
Founded2014
Employees
170
Employees170

STOK Key Statistics

Market cap
2.03B
Market cap2.03B
Price-Earnings ratio
-231.18
Price-Earnings ratio-231.18
Dividend yield
Dividend yield
Average volume
638.81K
Average volume638.81K
High today
High today
Low today
Low today
Open price
$35.05
Open price$35.05
Volume
0.00
Volume0.00
52 Week high
$40.22
52 Week high$40.22
52 Week low
$6.42
52 Week low$6.42

Stock Snapshot

Stoke Therapeutics(STOK) stock is priced at $35.03, giving the company a market capitalization of 2.03B. It carries a P/E multiple of -231.18.

Stoke Therapeutics(STOK) stock opened on 2026-04-13 at $35.05. The price climbed to — and dipped to —.

The Stoke Therapeutics(STOK)'s current trading volume is 0, compared to an average daily volume of 638.81K.

During the past year, Stoke Therapeutics(STOK) stock moved between $6.42 at its lowest and $40.22 at its peak.

During the past year, Stoke Therapeutics(STOK) stock moved between $6.42 at its lowest and $40.22 at its peak.

STOK News

Simply Wall St 5d
Did Stoke’s New R&D Chair Signal a Tighter Late-Stage Focus for STOK’s Pipeline Strategy?

Stoke Therapeutics recently expanded its Board of Directors to ten members and appointed G. Clare Kahn, Ph.D., as a Class I director and chair of the Research a...

Did Stoke’s New R&D Chair Signal a Tighter Late-Stage Focus for STOK’s Pipeline Strategy?
TipRanks 6d
Stoke Therapeutics Adds Veteran Leader to Board, R&D Oversight

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Analyst ratings

100%

of 12 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own STOK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.